Tobinco Can Never Deal In Fake Drugs - Former FDA Boss

Updated: 30-Sep-2013


A former Chief Executive of the Food and Drugs Authority (FDA), Hon. Emmanuel Kyeremateng Agyarko, has cautioned the authority to handle its communications effectively to avoid running down ‘innocent’ companies.

According to him, the choice of words when it comes to communicating to the public as far as drugs are concerned is very important; hence care must be taken.

Mr Kyeremanteng-Agyarko, who happens to also be the NPP Member of Parliament for Ayawaso West Wuogon Constituency, was analyzing the work of the Authority especially in relation to Tobinco Pharmaceuticals Limited and the recent allegation that the company produces fake drugs.

The FDA says its post market surveillance exercises conducted have disclosed that a variety of medicines imported into the country by Tobinco were yet to be approved and those on the market are counterfeit and unregistered.

However, the Pharmaceutical company strongly hit back in an official statement saying “Our drugs that were and are being destroyed by the FDA are not fake drugs.”

The company stated clearly that in its thirteen years in the pharmaceutical industry, it has operated honestly and complied with all regulatory requirements of the FDA. They also completely rejected the allegation that they are dealing in unwholesome products.

Speaking to the issue on Peace FM’s morning show ‘Kokrokoo’, Hon Agyarko indicated that “if there is risk, let us communicate it appropriately”.

He vouched for management of Tobinco; maintaining that they will ‘never’ deal in fake drugs and even if some of the products have not been registered, it does not make the drugs fake.

“Does it mean that everything he has done is wrong? Once you begin to make people feel that the company producing the drugs or the drugs itself is problematic, you create problems. FDA should go on with their duties however; I will plead with them to be cautious when communicating with the public (on issues of alleged fake drugs)...somebody like Tobinco will never indulge in producing or distributing counterfeit (medications)…he has no cause to do it…when it comes to these special products, the most important thing is the risk of communication…I want to encourage them (FDA) to do their work. They are like the last line of defense (medicallly) in this country but…” Kyeremanteng-Agyarko added.

Ridge Hospital In Dire Need Of “O –Negative” Blood Group
Vodafone Urges Ghanaians To Join In Fight Against TB
I Touched An Ebola Patient – Ghanaian Doctor Recalls Traumatic Experience In Liberia
Breaking News! Germanwing Co-pilot Deliberately Crashed Plane
Doctor Shortage Hits Wa
Accept NHIS Cards; GHS Directs Health Facilities
NHIS Crisis Explodes...
NHIS Crashes Cash & Carry Returns
Angry NHIS Card Holders Want 'Bailout'
Why Too Much Sleep Could Be Bad For You
National Health Insurance To Introduce Three Initiatives
NHIS Service Providers Stand By Decision To Charge Card Holders
Pepsodent Launches ‘Brush Day & Night’ School Programme On World Oral Health Day
The Effects Of Oils, Fats And Sugars In The Body
AIDS Commission Says HIV Test Should Not Be Mandatory
Health Insurance Biometric Registration Begins In VR
20,500 Cholera Cases Recorded As Of February 2015
FDA Inaugurates Task Force On Sub-standard Medicals
Reduce Micro-Nutrient Deficiencies - GHS
Tobacco Use On Decline Forts
Coconut Oil Prevents And Manages Diabetes-Scientist
Salty Water Damages Tema Hospital Equipment
High Income Earners Must Pay Higher NHIS Premiums
Registrar Worries About Cheating In Health Training Institutions
Health Minister Snubs Parliament Assurances Committee
Breman Asikuma Gets Nursing Training School
Measles Fear for Ebola-hit Countries
South Africans Perform First 'Successful' Penis Transplant
WHO Issues First Hepatitis B Treatment Guidelines
Delta Continues Malaria Prevention Efforts In Partnership With Ghana Red Cross Society